NTHI News
These Stocks are Lighting it Up
These names stand out for very different reasons: NeOnc Technologies (NASDAQ:NTHI), Hyperfine (NASDAQ:HYPR), bioAffinity Technologies (NASDAQ:BIAF), Profound Medical (NASDAQ:PROF), Wolfspeed (NYSE: WOLF) and Sunshine Biopharma (NASDAQ:SBFM).
24-7 Market News
These Stocks are Lighting it Up
These names stand out for very different reasons: NeOnc Technologies (NASDAQ:NTHI), Hyperfine (NASDAQ:HYPR), bioAffinity Technologies (NASDAQ:BIAF), Profound Medical (NASDAQ:PROF), Wolfspeed (NYSE: WOLF) and Sunshine Biopharma (NASDAQ:SBFM).
24-7 Market News
2026 Brings New Hope in the Fight Against Cancer as Breakthroughs Gather Momentum
NeOnc Technologies (NASDAQ:NTHI), Revolution Medicines (NASDAQ:RVMD), Moderna (NASDAQ:MRNA), Merck (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Genmab (NASDAQ:GMAB), and AbbVie (NYSE:ABBV) are among the companies contributing to a rapidly evolving cancer-treatment landscape in 2026, as researchers pursue new ways to extend survival, target tumors more precisely and give patients additional treatment options.
24-7 Market News
Brainiacs, Space Men, and Digital Assets
This week’s action puts Alector (NASDAQ:ALEC), NeOnc Technologies (NASDAQ:NTHI), WISeQey (NASDAQ:WKEY), Veea (NASDAQ:VEEA), and Stablecoin Development Corporation (NYSEAMERICAN:SDEV) squarely in that conversation.
24-7 Market News
Market Movers Go Wild and Lead Fresh Wave of Action
Today’s market action is being shaped by a striking mix of listings, including Alpha Modus Holdings (NASDAQ:AMOD), Stablecoin Development (NYSEAMERICAN:SDEV), Cycurion (NASDAQ:CYCU), ImmunityBio (NASDAQ:IBRX), XIAO-I Corporation (NASDAQ:AIXI), and NeOnc Technologies Holdings (NASDAQ:NTHI).
24-7 Market News
Stocks Exploding into October with Huge Catalysts
Stocks are charging into October with Nexalin Technology (NASDAQ:NXL), NeOnc Technologies Holdings (NASDAQ:NTHI), Airship AI Holdings (NASDAQ:AISP), DataMeds AI (NASDAQ:MEDS), Veea (NASDAQ:VEEA), Inseego (NASDAQ:INSG), and Enerflex (NYSE:EFXT) tied to developments that give investors fresh reasons to put these names on the radar.
24-7 Market News
Shredding Pounds, Trading Stocks—Lilly’s Potential Obesity Blockbuster and other Biotechs in Play
The biotech tape is entering a catalyst-heavy stretch, with NeOnc Technologies Holdings (NASDAQ:NTHI), Connect Biopharma (NASDAQ:CNTB), Valion Bio (NASDAQ:VBIO), Eli Lilly and Company (NYSE:LLY), Celcuity (NASDAQ:CELC), and Capricor Therapeutics (NASDAQ:CAPR) heading into important stretches, but for very different reasons.
24-7 Market News
High-Stakes October Puts These Biotechs in the Spotlight
The biotechnology sector is entering a catalyst-heavy stretch, with Iovance Biotherapeutics (NASDAQ:IOVA), NeOnc Technologies Holdings (NASDAQ:NTHI), and Summit Therapeutics (NASDAQ:SMMT) approaching potentially significant commercial, clinical, and regulatory milestones.
24-7 Market News
NeOnc’s Brain Cancer Pipeline Builds Toward a Major FDA Catalyst
NeOnc Technologies Holdings (NASDAQ:NTHI) is approaching a potentially important regulatory checkpoint as the company prepares for a November 17, 2026, in-person End-of-Phase 1 Type B meeting with the U.S. Food and Drug Administration regarding NEO212, its investigational oral perillyl alcohol-temozolomide conjugate being developed for difficult-to-treat central nervous system cancers. The meeting comes as NeOnc advances two clinical programs and builds a development pipeline increasingly centered on potential late-stage opportunities in brain cancer.
24-7 Market News
FDA Showdowns and Wins, AI Firepower and a 52-Week High
Kodiak Sciences (NASDAQ:KOD), NeOnc Technologies Holdings (NASDAQ:NTHI), KNOREX (NYSEAMERICAN:KNRX), DataMeds AI (NASDAQ:MEDS), Accuray (NASDAQ:ARAY) and AMC Entertainment (NYSE:AMC) are each approaching important milestones that could reshape how investors view their pipelines, platforms and near-term prospects.
24-7 Market News